Clinical Pharmacological Study of ASP1941 - A Clinical Pharmacological Study of ASP1941 in Subjects With Type 1 Diabetes Mellitus

Trial Profile

Clinical Pharmacological Study of ASP1941 - A Clinical Pharmacological Study of ASP1941 in Subjects With Type 1 Diabetes Mellitus

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Ipragliflozin (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 13 Apr 2016 Status changed from active, no longer recruiting to completed.
    • 17 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
    • 30 Sep 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top